`
`PUBLIC VERSION
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`
`NJOY, LLC,
`NJOY HOLDINGS, INC.,
`Petitioners,
`
`v.
`
`JUUL LABS, INC.,
`Patent Owner
`________________
`
`Case IPR2024-00231
`U.S. Patent No. 10,130,123
`________________
`
`
`
`
`
`
`DECLARATION OF DR. JOHN COLLINS
`
`IN SUPPORT OF PATENT OWNER’S PRELIMINARY RESPONSE
`
`
`
`
`
`
`
`JLI Ex. 2001
`
`08755-00011A/14778095.1
`
`
`
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`1.
`
`I have been retained on behalf of JUUL Labs, Inc. (“Patent Owner”) in
`
`connection with the above-captioned inter partes review (IPR). I have been retained
`
`to provide my opinions in support of Patent Owner’s Preliminary Response. I am
`
`being compensated for my time at the rate of $450 per hour. I have no interest in the
`
`outcome of this proceeding.
`
`2.
`
`In preparing this declaration, I have reviewed and am familiar with the
`
`Petition for IPR2024-00231, U.S. Patent No. 10,130,123 (“the ’123 patent”) and its
`
`file history, and all other materials cited and discussed in the Petition (including the
`
`declaration of Petitioner’s expert Joseph McAlexander), and cited and discussed in
`
`this Declaration.
`
`3.
`
`The statements made herein are based upon my own knowledge and
`
`opinion. This Declaration represents only the opinions I have formed to date. I may
`
`consider additional documents as they become available or other documents that are
`
`necessary to form my opinions. I reserve the right to revise, supplement, or amend
`
`my opinions based on new information and on my continuing analysis.
`
`I.
`
`QUALIFICATIONS
`
`4.
`
`I have been employed since 2008 at the Consortia for Improving
`
`Medicine with Innovation and Technology (“CIMIT”) and am currently the Director
`
`of Innovation Platforms. CIMIT is a non-profit consortium of Boston’s leading
`
`teaching hospitals and universities along with a growing network of national and
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 1
`
`
`
`international affiliates. CIMIT is an operating unit within Massachusetts General
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`Hospital where I have a faculty appointment.
`
`5. Much of my responsibility at CIMIT is to facilitate collaboration among
`
`scientists, engineers, clinicians, and entrepreneurs to speed the discovery,
`
`development, and implementation of medical innovations into practice. I focus on
`
`assisting investigators in moving technologies from the lab into products and
`
`services that improve patient care. My focus has been on developing and
`
`implementing CIMIT’s CoLab and GAITS platforms.
`
`6.
`
`By way of example of CIMIT’s work, it was recently responsible for
`
`the National Institute of Biomedical Imaging and Bioengineering (NIBIB)
`
`sponsored RADx Tech program. The program has committed more than $1.5 Bn to
`
`develop and accelerate the commercialization of innovative point of care SARS-
`
`CoV-2 (COVID) tests into practice. That program supported more than 100
`
`organization and resulted in 55 FDA authorized tests, including the 1st over-the-
`
`counter test for home use, and the production of over 7 billion tests1.
`
`7.
`
`Also since 2008, I have been employed as the Chief Technology and
`
`Innovation Officer for Reed Collins, LLC. At Reed Collins, I provide consulting to
`
`
`1 See NIH Website, accessed 2/28.2024: https://www.nibib.nih.gov/covid-19/radx-
`
`tech-program
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 2
`
`
`
`non-profits as well as start-ups. Non-profit clients include Oxford University in the
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`UK and Howard University in the US.
`
`8.
`
`I received a Ph.D. (1988) and M.S. (1982) in mechanical engineering
`
`from the Massachusetts Institute of Technology (“MIT”), as well as a B.S. (1980) in
`
`mechanical engineering, with a minor in economics, from Rensselaer Polytechnic
`
`Institute (“RPI”). At MIT, I worked in the Fluids Lab under the direction of
`
`Professors Asher Shapiro and Roger Kamm. My academic work focused on
`
`mechanical engineering with a concentration on fluid dynamics and heat/mass
`
`transfer, with my Ph.D. and M.S. theses applying these principles to pulmonary
`
`dynamics. My M.S. thesis was on high frequency ventilation: at the time a novel
`
`way to ventilate babies without over-pressurization of the lung, avoiding damage to
`
`the lung during ventilator assist. My Ph.D. thesis was on analytical and numerical
`
`modeling of forced exhalation from the lung. The results were a computational
`
`model of the lung that allowed for more sophisticated diagnostics based on the
`
`results of the simple Forced Expiration Pulmonary Function (“FEPF”) test.
`
`9.
`
`I now have over 40 years of product design, development, and
`
`consulting experience covering a wide range of industries and products. Over that
`
`time, I have had a consistent focus on medical devices and related technologies,
`
`which includes my particular expertise in design, fluid mechanics and heat/mass
`
`transfer. In addition to doing engineering work, my responsibilities have included
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 3
`
`
`
`assembling and managing teams to develop new consumer, industrial, and medical
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`products.
`
`10.
`
`I also have experience as an innovator and inventor. I am a named
`
`inventor on more than twenty U.S. patents, with foreign counterparts in addition, on
`
`new products and manufacturing processes. My CV is attached as Exhibit 2002 and
`
`contains a list of my US Patents and all the publications that I have authored in the
`
`last 10 years.
`
`11. Prior to my time at CIMIT and Reed Collins LLC in 2008, I held
`
`various leadership positions at technology and product development companies.
`
`From 1982-1986, I worked at Booz, Allen & Hamilton, where I developed a number
`
`of consumer and industrial products. After taking time to return to MIT and complete
`
`my Ph.D., I was then employed by Arthur D. Little (“ADL”) until 1988. I then joined
`
`ADL as a design engineer and helped form its medical products business. I
`
`progressed to being responsible for the Technology and Innovation (“T&I”)
`
`Directorate, with more than 250 staff as Sr Vice President until 2002.
`
`12. From 2002-2008, I worked in close collaboration with CEO and owner,
`
`Dr. Kenan Sahin, to form TIAX LLC from the resources of the ADL T&I
`
`Directorate. TIAX is and was a privately held technology transformation
`
`organization
`
`focused on
`
`advancing
`
`and developing
`
`technologies
`
`for
`
`commercialization in several core technology areas, including clean energy and
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 4
`
`
`
`materials, health and wellness, appliances and HVAC systems, and enhanced
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`security. During my tenure at TIAX, part of which I served as president, the World
`
`Economic Forum recognized TIAX as a Technology Pioneer in 2002 and as a New
`
`Champion in 2007. For a full list of my employment history, see my CV, attached
`
`as Exhibit A to this report.
`
`13. My experiences cover a broad technology base across a diverse set of
`
`industries, including in the areas of medical devices, energy, consumer products,
`
`emission technology for automobiles, and alternative smoking products.
`
`14. By way of example, while at ADL, I worked with an operating unit
`
`within Philip Morris USA (“PM USA”) called Chrysalis Technologies, Inc.
`
`(“Chrysalis”) on an alternative smoking product that was battery-powered and puff-
`
`activated. Also, while at ADL, and then continuing that work at TIAX, I continued
`
`that work with Chrysalis on several related projects. These projects built off of and
`
`utilized the prior capillary aerosol generator research and development at PM USA
`
`and Chrysalis (the results of which are reflected in patents such as U.S. Pat. No.
`
`5,743,251 to Howell et al.; U.S. Pat. No. 6,501,052 to Cox et al.; and U.S. Pat. No.
`
`6,491,233 to Nichols) and applied it to efforts to atomize very low flow rates of
`
`liquid fuel for efficient combustion. One application was for a low-power, fuel based
`
`electric power generator (U.S. Pat. App. No. 2006/0093977 to Pellizzari I), and
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 5
`
`
`
`another was for a clean emission “coldstart” fuel injector for automobiles (U.S. Pat.
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`No. 7,059,307 to Pellizzari II).
`
`15. By way of further examples of products that I have worked on, I worked
`
`with Baxter Healthcare to develop a blood/fluid warmer based on the analytical
`
`optimization of the thermal performance of “conventional” resistance heating
`
`technology; Bausch & Lomb to develop a microsurgical fluid delivery system that
`
`allowed the surgeon to control the flow or pressure of irrigation fluid; and Johnson
`
`& Johnson to develop Trocars and clip appliers for minimally invasive surgery.
`
`16.
`
`I have also performed services in numerous patent disputes as an
`
`independent technical expert and consultant and as an expert witness. I have
`
`consulted as an expert in matters involving the design of a variety of medical devices.
`
`See Exhibit 2002 for a list of matters in which I have offered expert opinions or
`
`testified in court in the last 4 years as well as all prior e-cigarette cases in which I
`
`testified or offered expert opinions. In total, I have worked on, testified or offered
`
`expert opinions in eight other e-cigarette cases.
`
`II. LEGAL UNDERSTANDING
`
`A. The Person of Ordinary Skill in the Art (“POSITA”)
`
`17.
`
`I understand that a person of ordinary skill in the relevant art at the time
`
`of the invention (also referred to herein as “ordinary artisan”) is presumed to be
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 6
`
`
`
`aware of all pertinent art, thinks along conventional wisdom in the art, and is a person
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`of ordinary creativity—not an automaton.
`
`18.
`
`I have been asked to consider the level of ordinary skill in the field that
`
`someone would have had at the time the claimed invention was made. In deciding
`
`the level of ordinary skill, I considered the following:
`
`• the levels of education and experience of persons working in the
`
`field;
`
`• the types of problems encountered in the field; and
`
`• the sophistication of the technology.
`
`19. A person of ordinary skill in the art relevant to the ’123 patent at the
`
`time of the invention would have a B.S. in mechanical engineering, electrical
`
`engineering, or an equivalent degree, and either at least two years of experience
`
`designing electro-mechanical consumer products or an advanced degree in
`
`mechanical engineering, electrical engineering, or an equivalent field.
`
`20.
`
`I have reviewed the declaration of Mr. McAlexander, including his
`
`opinions regarding the Person of Ordinary Skill in the Art. Mr. McAlexander
`
`provides a similar definition of a POSITA: “at least a B.S. degree in Mechanical
`
`Engineering, Electrical Engineering, Industrial Design, Product Design, or similar
`
`field, with at least two years of industry experience in one of these fields; and such
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 7
`
`
`
`POSA would have been familiar with electrically powered vaporizing articles, their
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`components, or the underlying technologies.” Ex. 1003, ¶27.
`
`21. My opinions set forth in this Declaration would be the same under
`
`either my or Mr. McAlexander’s proposal.
`
`22.
`
`I am well-qualified to determine the level of ordinary skill in the art and
`
`am personally familiar with the technology of the ’123 patent. I was a person of at
`
`least ordinary skill in the art at the time of the priority date of the ’123 patent
`
`regardless of which definition used. Regardless if I do not explicitly state that my
`
`statements below are based on this timeframe, all of my statements are to be
`
`understood as an ordinary artisan would have understood something as of the priority
`
`date of the ’123 patent.
`
`B.
`
`Legal Principles
`
`23.
`
`I am not a lawyer and will not provide any legal opinions. Though I am
`
`not a lawyer, I have been advised that certain legal standards are to be applied by
`
`technical experts in forming opinions regarding the meaning and validity of patent
`
`claims.
`
`1.
`
`Anticipation
`
`24.
`
`I understand that to obtain a patent, a claimed invention must have, as
`
`of the priority date, been novel. I understand that to prove that a prior art reference
`
`anticipates a patent, the four corners of the prior art reference must describe element
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 8
`
`
`
`of the claimed invention, either expressly or inherently. I also understand that the
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`prior art reference must describe the elements arranged as in the claim and that it is
`
`improper to combine disparate embodiments to establish anticipation unless a
`
`POSITA when reading the reference could at once envisage such a combination.
`
`2.
`
`Obviousness
`
`25.
`
`I understand that to obtain a patent, a claimed invention must also have,
`
`as of the priority date, been nonobvious in view of prior art in the field. I understand
`
`that an invention is obvious when the differences between the subject matter sought
`
`to be patented and the prior art are such that the subject matter as a whole would
`
`have been obvious at the time the invention was made to a person having ordinary
`
`skill in the art.
`
`26.
`
`I understand that to prove that prior art, or a combination of prior art,
`
`renders a patent obvious, it is necessary to: (1) identify the particular references that
`
`singly, or in combination, make the patent obvious; (2) specifically identify which
`
`elements of the patent claim appear in each of the asserted references; and (3) explain
`
`how the prior art references could have been combined to create the inventions
`
`claimed in the asserted claim.
`
`27.
`
`I understand that a patent composed of several elements is not proved
`
`obvious merely by demonstrating that each of its elements was, independently,
`
`known in the prior art, and that obviousness cannot be based on the hindsight
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 9
`
`
`
`combination of components selectively culled from the prior art to fit the parameters
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`of the patented invention.
`
`28.
`
`I also understand that a reference may be said to teach away when a
`
`person of ordinary skill, upon reading the reference, would be discouraged from
`
`following the path set out in the reference, or would be led in a direction divergent
`
`from the path that was taken by the applicant. Even if a reference is not found to
`
`teach away, I understand its statements regarding preferences are relevant to a
`
`finding regarding whether a skilled artisan would be motivated to combine that
`
`reference with another reference.
`
`3. My Understanding of Claim Construction Law
`
`29.
`
`I have been informed that patent claims are construed from the
`
`viewpoint of a person of an ordinary artisan and that patent claims generally should
`
`be understood consistent with their ordinary and customary meaning at the time of
`
`the invention. A review of the patent claim language, the patent specification, and
`
`its prosecution history are also necessary to determine the proper meaning and scope
`
`of the term at issue.
`
`30.
`
`I have further been informed that in the specification and prosecution
`
`history the patentee may define a claim term in a way that differs from the ordinary
`
`and customary meaning. I understand that during prosecution of the patent before
`
`the U.S. Patent and Trademark Office, the Applicant may make representations or
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 10
`
`
`
`provide definitions of terms that may affect the scope of the patent claims. In
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`particular, the Applicant may, during the course of prosecution, limit the scope of
`
`the claims to overcome prior art and/or disavow claim coverage by making clear and
`
`unambiguous statements to that effect.
`
`31.
`
`I have been informed that an ordinary artisan may, among other things,
`
`consider dictionaries, publications, other patents, and treatises (i.e., “extrinsic
`
`evidence”). I understand that extrinsic evidence may generally not be relied on if it
`
`contradicts the meaning of claim language provided by the intrinsic evidence, such
`
`as express definitions given for terms in the specification.
`
`4.
`
`Secondary Considerations of Non-Obviousness
`
`32.
`
`I understand that one of the factual inquiries when determining the
`
`obviousness of a patent is to consider objective evidence related to the issue of
`
`obviousness, sometimes called “secondary considerations of non-obviousness” or
`
`“objective indicia of non-obviousness.” I understand that such evidence can often
`
`be probative of the issues of obviousness.
`
`33.
`
`I understand that examples of objective evidence include (1)
`
`commercial success, (2) copying, (3) industry praise, (4) skepticism, (5) long-felt
`
`but unsolved need, and (6) failure of others.
`
`34.
`
`I understand that there must be a nexus between the patented invention
`
`and the evidence of secondary considerations. I further understand that there is a
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 11
`
`
`
`presumption of such a nexus if the claims of the patent are coextensive with a product
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`or products that are the subject of the secondary considerations evidence. I further
`
`understand that in order for a claim to be coextensive with a product, one must look
`
`at the claims at the whole and not just the new claimed feature. In addition, the
`
`claimed invention should not be merely a subcomponent of the products sold but
`
`should encompass the entire apparatus.
`
`III. CLAIM CONSTRUCTION
`
`35.
`
`In my opinion, all claim terms should be given their ordinary meaning
`
`in light of the specification.
`
`36. Petitioners mention that the construction of the term “pressure value”
`
`was disputed in the parallel ITC investigation. I understand that the construction of
`
`that term is no longer in dispute.
`
`37.
`
`In my opinion, for purposes of deciding institution of the Petition in this
`
`preliminary stage, it is not necessary for the Board to resolve this construction.
`
`IV. GROUND 1: PETITIONERS DO NOT SHOW THAT WORM
`ANTICIPATES THE CHALLENGED CLAIMS
`
`38.
`
`In my opinion, Worm does not anticipate any of the challenged claims
`
`of the ’123 patent.
`
`39.
`
`In my opinion, Worm does not expressly or inherently disclose a
`
`“sealed air flow path passing from an air inlet, through the channel and to a heater
`
`and an outlet of a mouthpiece” where the channel is “formed between an interior
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 12
`
`
`
`surface of the cartridge receptacle and an exterior surface of the cartridge.” As I
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`explain below, Worm instead teaches that air enters the device through a different
`
`air inlet and takes a different path to the mouthpiece that does not pass through any
`
`channel between the cartridge and the receptacle as the claims require.
`
`A. Worm does not anticipate an “air flow path passing from an air
`inlet, through the channel and to a heater and an outlet of a
`mouthpiece”
`
`40. The independent claims 14 and 27 of the ’123 patent require a specific
`
`“air flow path” that originates from an air inlet, travels through a channel “formed
`
`between an interior surface of the cartridge receptacle and an exterior surface of
`
`the cartridge” to a heater, and then goes out of a mouthpiece.
`
`41. Although Petitioners try to show Worm discloses such an “air flow
`
`path,” Worm does not. In doing so, Petitioners rely on a purported air inlet and
`
`purported channel that is not disclosed by Worm. Worm instead discloses an air
`
`inlet and channel that does not meet the claims, which I presume is why Petitioners
`
`do not rely on Worm’s express teachings.
`
`42. Specifically, Worm discloses that when air is drawn from the
`
`mouthpiece, it “causes air to enter the air inlet channel 788 … through one or more
`
`air inlet apertures 789 and flow into the air flow entry 741a … from which the
`
`drawn air passes through the interior of the base 740 [which is in cartridge 704]
`
`and into the cartridge 704,” after which the airflow “proceed[s] … toward the
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 13
`
`
`
`mouthend of the cartridge.” Ex. 1004, ¶75. This airflow path described in Worm
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`is illustrated below in this version of Figure 7 which I have annotated.
`
`
`
`43. As one can see, Worm expressly discloses that when a user puffs on
`
`the device, air flows into the device via the center air flow inlet, and then air flows
`
`down the center of the device. Airflow traverses through the interior of the control
`
`body 702 and proceeds straight into the central air flow entry 741 hole at the
`
`bottom of the cartridge 704. For example, as shown in the separate embodiment of
`
`Figures 3-6 (namely, the cross-section of Figure 6B), air enters through apertures
`
`389a and 389b, then travels toward the middle of the air inlet channel 388 where a
`
`wider portion of the channel is formed. This is shown in the green arrows which I
`
`have added.
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 14
`
`
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`
`
`44. Petitioners and Mr. McAlexander do not rely on this express
`
`disclosure. Instead, they assume the presence of a different air inlet and channel
`
`that is not at all described in Worm and which a POSITA would in fact not
`
`consider to be present in the device due to its many disadvantages. This is shown
`
`in their heavily annotated version of Figure 7 below.
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 15
`
`
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`
`
`45. There are several unsupported assumptions that Petitioners make.
`
`First, Petitioners assert that “Worm depicts the non-airtight interface (channel) as a
`
`uniform gap between cartridge 704 and control body 702.” Pet. 17. This is in
`
`direct conflict with Worm what teaches and a POSITA would understand. Rather
`
`than being a uniform gap, this space is where the electrical contacts in the
`
`cartomizer and body must touch each other. Ex. 1004, ¶58.
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 16
`
`
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`46.
`
`Second, Petitioners assume that there are additional air inlets beyond
`
`the “one or more air inlet apertures 789” already taught in Worm. Ex. 1004, ¶75.
`
`Worm does not teach any such air inlets, nor is there any reason for such air inlets
`
`given the presence of the air inlet apertures 789.
`
`47. Third, Petitioners assume that air flows from these additional air inlets
`
`through a winding passage into the center of the device. Worm does not disclose
`
`anywhere that such additional air inlets or passage exist. And as I explain below,
`
`the fluid mechanics of such a passageway, to the extent it even exists, winding up
`
`and down along the protrusions forming the “cavity” in Worm, would likely cause
`
`a reduction in airflow at every turn, such that the primary air inlet passageway,
`
`already taught in Worm, would control.
`
`48. Petitioners argue the presence of this additional air inlet and passage
`
`because of a gap depicted in Figure 7. But I understand that figures generally
`
`should not be relied upon to show specific dimensions or sizes when a
`
`specification is silent.
`
`49. Moreover, the specification explicitly describes that the two faces of
`
`the supposed uniform gap must touch each other to make an electrical contact and
`
`is completely silent on the existence and function of the alleged air inlets or gaps.
`
`50. Worm does disclose “channel 725” connected to “pressure channel
`
`785,” which is marked orange in the below annotated figure. Pet. 36 (citing Ex.
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 17
`
`
`
`1004, ¶76). As Worm explains it, this path allows the pressure drop from the
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`inhalation to be “communicated to the pressure channel,” and “does not
`
`substantially form an air tight connection.” Ex. 1004, ¶76.
`
`
`
`51. But in my opinion, there is simply no disclosure or need for the
`
`airflow path to extend past the pressure chamber—indeed, Worm states that the
`
`pressure chamber is an “isolated segment of the device.” Id., ¶5. Moreover, unlike
`
`the airflow path from the air inlet 789 to the user’s mouth which impacts the user
`
`draw experience, the uniformity of the path to the pressure chamber is not
`
`important as the amount of air movement required is negligible.
`
`52.
`
`In my opinion, a POSITA would also not understand that Petitioners’
`
`additional inlet and gap, to the extent it exists, is for airflow because Worm does
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 18
`
`
`
`not provide any disclosure about the presence, size, or purpose of Petitioners’ inlet
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`or gap. A POSITA would instead understand that airflow travels through the inlets
`
`and passages as already described in Worm (namely, the air inlet aperture 789).
`
`53.
`
`In addition, a POSITA would consider the winding path alleged by
`
`Petitioners to be ineffective for providing airflow—in fact, a POSITA would
`
`understand that “labyrinth seals,” which use pathways such as shown in Worm,
`
`could be used to seal connections from fluids. Labyrinth seals are just one type of
`
`mechanical seal that prevents airflow through a connection between components
`
`using nothing more than the geometry of the passageway. It is well-known that a
`
`right angle in a small passageway, like the one allegedly shown in Worm,
`
`diminishes airflow and causes a corresponding drop in any transmitted pressure.
`
`The gap Petitioners allege to be a channel has several of these angles. It is also
`
`well-known among ordinary artisans that airflow is a function of the size of the
`
`passageway and, even if Worm did teach a “gap,” it would be so small and
`
`minimize airflow, particularly when there is another source of airflow (the
`
`disclosed air inlet aperture) that would control the airflow in the device.
`
`54. Also, if this gap exists, it would likely be sealed from airflow during a
`
`user puff. As I have illustrated in the below modified Figure 7, when a user
`
`inhales on the mouthpiece of the cartridge 704, the control body 702 and cartridge
`
`704 will be pulled together to form a seal. The resulting negative pressure event is
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 19
`
`
`
`still detected by the pressure sensor 708, becauseit is in fluid communication with
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`the cavity 725 through the pressure channel 785. However, airflow through
`
`Petitioners’ alleged gap would be substantially limited by this sealing action. As
`
`such, a POSITA would clearly understandthatairflow is not intended to pass
`
`through the alleged gap andinto the cartridge 702. Such a pathway would not be
`
`suitable for its intended purpose.
`
`/4{
`785a
`724 741a
`
`
`
`
`
`
`
`
`
`SPpe \¥SNLKAe<i
`
`796
`
`
`
`
`
`
`
`
`55.
`
`For similar reasons, if the gap exists as Petitioners allege, there would
`
`be variability in the size of the gap andair inlet depending on usage. As I explain
`
`below, such variability is undesirable because it would have an uncontrollable
`
`effect on user experience.
`
`56.
`
`The specification is also clear that the areas that the Petitioner claims
`
`are “a uniform gap betweencartridge 704 and control body 702”is incorrect. Pet.
`
`17. Specifically, the specification describesthat the electrically conductive heater
`08755-00011A/14778095.1
`JLI Ex. 2001, Page 20
`
`
`
`terminals 138 are configured to direct current flow through the heating element and
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`from the battery 110 when the cartridge 104 is connected to the control body. Ex.
`
`1004, ¶38. The plug 140 engages the coupler 120 to form an electrical connection
`
`so that an electrical current can flows from the battery 110, through the coupler and
`
`plug, and to the heating element 134. Id. As such, portions of the electrical
`
`contacts in the battery portion (361, 362, and 363) must touch the corresponding
`
`contacts in the cartridge.
`
`V. GROUND 2: PETITIONERS DO NOT SHOW THAT WORM
`RENDERS OBVIOUS THE CHALLENGED CLAIMS
`
`57.
`
`In my opinion, Worm does not render obvious the challenged claims.
`
`Petitioners present this ground as an alternative to Ground 1, stating that “it would
`
`have been obvious to a POSA that the channel formed between the cartridge
`
`receptable [sic] and cartridge of Worm permits air to enter the cavity.” Pet. 50. As
`
`I explained above, Worm does not disclose any such channel. I also believe Worm
`
`does not render obvious any such channel. As I explain below, such a channel
`
`would actually be undesirable for several reasons.
`
`58. As an initial matter, I note that Petitioners do not actually provide any
`
`rationale for why a POSITA would modify Worm to provide such an air inlet and
`
`airflow channel.
`
`59. Petitioners argue that the gap in Figure 7 is “depicted as a uniform
`
`gap” and therefore would be obvious to allow airflow. Pet. 50 (quoting Ex. 1004,
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 21
`
`
`
`¶76). As I explained above, it is my understanding that patent figures cannot
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`convey specific dimensions or sizes without support for the specification, and the
`
`specification does not state anywhere that the gap is uniform, let alone that it
`
`exists. As I also explained above, Worm’s disclosures make it clear that the gap
`
`cannot be uniform due to the presence of electrical contacts. Moreover, the
`
`distance between the housing and cartridge varies with use, including the
`
`formation of a seal when the cartridge is pulled toward the cavity when a user
`
`inhales.
`
`60. Petitioners’ alleged airflow channel is also undesirable to a POSITA.
`
`As I mentioned above, Worm already discloses an airflow inlet and channel. It
`
`would be undesirable to add an additional inlet and channel as proposed by
`
`Petitioners because such an inlet and channel would be difficult to control and
`
`thereby harm user experience.
`
`61. A POSITA would understand that the amount of airflow in an e-
`
`cigarette must be tightly controlled to allow for an adequate user experience—and
`
`such tight control requires strict engineering. It was known that the size, shape, and
`
`location of air inlets and air passages affects draw resistance, which impacts,
`
`among other things, vapor production, the size of the visible vapor cloud, and
`
`nicotine delivery to a user. These are details that must be carefully balanced so that
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 22
`
`
`
`the use of the vaporizer simulates the experience of using a cigarette. Petitioners
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`ignore such details and do not even argue the limitation is obvious.
`
`62.
`
`I note that these considerations were made by the inventors of the
`
`’123 patent as they designed the JUUL Device (which I explain below is embodied
`
`in the ’123 patent). The inventors recognized that draw resistance, and the airflow
`
`that contributes to it, must be tightly controlled. See, e.g., Ex. 2003, 26 (“
`
`
`
`
`
`
`
`
`
`
`
`
`
`”). Others working in the e-cigarette space at the time of the ’123 Patent’s
`
`invention similarly recognized that many factors contribute to the user experience,
`
`including the design of the aerosol formation chamber. See Ex. 2023, ¶50.
`
`63. Petitioners, on the other hand, do not account for these factors in
`
`arguing that it would be obvious the alleged gap is an airflow gap.
`
`64.
`
`In order to control the amount of airflow that results in an optimal
`
`user experience, it would be preferable and simpler to engineer the size of the air
`
`inlet 789 and air passage 788 expressly described in Worm for the optimal
`
`dimensions. By contrast, the additional air inlet and passage as proposed by
`
`08755-00011A/14778095.1
`
`
`JLI Ex. 2001, Page 23
`
`
`
`Petitioners are based on several factors that can vary in use, such as the shape of
`
`PUBLIC VERSION
`
`IPR2024-00231
`
`the electrical contacts as well as the distance the cartridge is inserted into the
`
`control body which is affected by multiple tolerance stack-ups2 and by extraneous
`
`factors such as wear and tear of the protrusion/recess mechanism or the amount of
`
`inhalation force applied by the user to the cartridge moving towards the control
`
`body. Petitioners’ alleged air inlet and passage therefore cannot